PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Spermidine Synthase 277 Target Disease Infection 766,637 7 0.00 -0.99 0.03 0.52
Retinoic Acid Receptor Gamma-1 6 Target Disease Infection 766,637 1 0.00 -0.91 0.17 0.55
ApoE2 517 Target Disease Infection 766,637 9 0.00 -0.99 0.02 0.52
AMBP 160 Target Disease Infection 766,637 5 0.00 -0.98 0.03 0.53
A1M 59 Target Disease Infection 766,637 3 0.00 -0.97 0.05 0.54
APOH 110 Target Disease Infection 766,637 4 0.00 -0.98 0.04 0.53
AP2M1 7 Target Disease Infection 766,637 1 0.00 -0.93 0.14 0.55
Atosiban 274 Target Disease Infection 766,637 6 0.00 -0.99 0.02 0.52
CD62L/L-Selectin 8 Target Disease Infection 766,637 1 0.00 -0.94 0.12 0.55
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
ENO2 87 Target Disease Infection 766,637 3 0.00 -0.98 0.03 0.53
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
BLK 255 Target Disease Infection 766,637 5 0.00 -0.99 0.02 0.52
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
BAFFR 44 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
Dopamine Receptor D3 45 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
High Affinity Nerve Growth Factor Receptor 47 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Phosphodiesterase 4b 54 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
FABP3 134 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
CCNB1 160 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
Histamine H1 Receptor 1,170 Target Disease Infection 766,637 8 0.00 -1.00 0.01 0.50
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
Chorismate Synthase 85 Target Disease Infection 766,637 2 0.00 -0.99 0.02 0.52
DDR2 194 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.51
Collagenase-3 367 Target Disease Infection 766,637 4 0.00 -0.99 0.01 0.51
Estrogen Receptor Beta 1,924 Target Disease Infection 766,637 9 0.00 -1.00 0.00 0.49
Epigen 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
DAPK2 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
Sodium Channel Nav1.8 31 Target Disease Infection 766,637 1 0.00 -0.98 0.03 0.53
CAMK2A 42 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
DNAJB1 44 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Infection 766,637 2 0.00 -1.00 0.01 0.50
Glutathione S-Transferase Theta-1 70 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
EPHA4 357 Target Disease Infection 766,637 2 0.00 -1.00 0.01 0.49
Adenosine A1 Receptor 1,432 Target Disease Infection 766,637 4 0.00 -1.00 0.00 0.48
B-R1 90 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
Cytokeratin 20 847 Target Disease Infection 766,637 3 0.00 -1.00 0.00 0.48
ACRP30 102 Target Disease Infection 766,637 1 0.00 -1.00 0.01 0.50
Aurora B kinase 415 Target Disease Infection 766,637 2 0.00 -1.00 0.00 0.49
N-Type Calcium Channel 453 Target Disease Infection 766,637 2 0.00 -1.00 0.00 0.49
Adenosine A3 Receptor 164 Target Disease Infection 766,637 1 0.00 -1.00 0.01 0.50
Artemin 184 Target Disease Infection 766,637 1 0.00 -1.00 0.01 0.49
Epidermal Growth Factor Receptor 24,772 Target Disease Carcinoma 433,099 4,400 0.04 -0.90 0.18 0.64
Cytokeratin 20 847 Target Disease Carcinoma 433,099 449 0.02 -0.69 0.53 0.63
Androgen Receptor 12,918 Target Disease Carcinoma 433,099 928 0.01 -0.96 0.07 0.59
CD4 112,219 Target Disease Carcinoma 433,099 1,988 0.01 -0.99 0.02 0.56
CD68 6,424 Target Disease Carcinoma 433,099 448 0.01 -0.96 0.07 0.58
Endostatin 1,599 Target Disease Carcinoma 433,099 211 0.01 -0.93 0.13 0.59